Elanco Animal Health Inc (ELAN): Shareholders' Equity
$6.55B
As of 2025-12-31
$6.59B
As of 2026-06-30
-3.5%
3-year compound annual growth
-5.0%
5-year compound annual growth
| Period ended | Shareholders' Equity | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $6.55B | +7.4% | 2026-02-24, Balance as of period end |
| 2024-12-31 | $6.10B | -2.0% | 2026-02-24, Balance as of period end |
| 2023-12-31 | $6.22B | -14.6% | 2026-02-24, Balance as of period end |
| 2022-12-31 | $7.29B | -2.9% | 2025-02-25, Balance as of period end |
| 2021-12-31 | $7.51B | -11.2% | 2024-02-26, Balance as of period end |
| 2020-12-31 | $8.46B | +52.5% | 2023-03-01, Balance as of period end |
| 2019-12-31 | $5.55B | +6.7% | 2022-02-28, Balance as of period end |
| 2018-12-31 | $5.20B | -33.2% | 2021-03-01, Balance as of period end |
| 2017-12-31 | $7.78B | +10.9% | 2020-02-28, Balance as of period end |
| 2016-12-31 | $7.02B | n/a | 2019-02-20, Balance as of period end |
Shareholders' Equity at similar companies
| Company | Year ended | Shareholders' Equity | Change YoY |
|---|---|---|---|
| Elanco Animal Health Inc (ELAN) | 2025-12-31 | $6.55B | +7.4% |
| Jazz Pharmaceuticals plc (JAZZ) | 2025-12-31 | $4.32B | +5.5% |
| Perrigo Co PLC (PRGO) | 2025-12-31 | $2.94B | -32.0% |
| BeOne Medicines Ltd. (ONC) | 2025-12-31 | $4.36B | +30.9% |
| Alnylam Pharmaceuticals, Inc. (ALNY) | 2025-12-31 | $789.18M | n/m |
| Organon & Co. (OGN) | 2025-12-31 | $752.00M | +59.3% |
| BioMarin Pharmaceutical Inc (BMRN) | 2025-12-31 | $6.09B | +7.6% |
| United Therapeutics Corp (UTHR) | 2025-12-31 | $7.10B | +10.1% |
| Amneal Pharmaceuticals, Inc. (AMRX) | 2025-12-31 | -$70.79M | n/m |
Compare ELAN, JAZZ, PRGO, ONC side by side · Screen every company in Pharmaceutical Preparations ↗